Patent · US Active

Prodrug-type anticancer agent using cancer-specific enzymatic activity

US11655269B2 · kind B2 · utility

0Cited by
1References
4Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 4, 2019
Grant dateMay 23, 2023
Priority date—
Expiry dateMar 4, 2039

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07F7/1804
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

To provide novel compounds that are promising as prodrug-type anticancer agents, a compound represented by general formula (I) or a salt thereof is provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.